The Agonorexia Epidemic: How Weight-Loss Pens Are Rewriting Our Relationship with Health and the Looming Risks of Biohacking A staggering 16% of young adults report considering weight-loss medications, even without a medical need, according to recent surveys. This isn’t just about vanity; it’s a symptom of a deeper societal shift – a growing willingness to … Read more
Brazil’s Obesity Treatment Landscape: Wegovy’s Arrival Signals a New Era of Competition and Access Over 20% of adults in Brazil are now classified as obese, a figure that’s rapidly climbing alongside rising rates of type 2 diabetes and cardiovascular disease. This escalating health crisis is poised for a significant shift as Novo Nordisk submits Wegovy, … Read more
The global fight against obesity has entered a new era. The World Health Organisation’s (WHO) recent endorsement of GLP-1 drugs like semaglutide (Ozempic/Wegovy) isn’t merely an acknowledgement of their efficacy – it’s a fundamental shift in how we understand and treat a disease affecting over a billion people worldwide. This move, coupled with ongoing research … Read more
The Ozempic Cliff: Why Weight Loss Drugs Demand a Lifetime Commitment to Lifestyle Change Four times faster. That’s how quickly individuals regain weight after discontinuing medications like Ozempic, Wegovy, and similar GLP-1 receptor agonists, compared to those who lose weight through diet and exercise alone. This startling statistic, emerging from a growing body of research … Read more
The Ozempic Plateau: Why Weight Loss Drugs May Be a Lifelong Prescription A startling statistic is emerging from recent studies: nearly two-thirds of individuals regain a significant portion of weight lost while on GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro within two years of stopping treatment. This isn’t simply a matter of willpower; it’s … Read more
The rapid rise of telehealth-driven weight-loss treatments, particularly those utilizing GLP-1 medications like Ozempic and Wegovy, is facing increasing scrutiny. While offering potential benefits for individuals struggling with obesity, the aggressive marketing tactics employed by some companies – including Black Friday sales and circumvention of advertising regulations – are raising serious concerns about patient safety … Read more